Merck Advances Pediatric Oncology with Innovative ADC Modeling Case Study Merck Advances Pediatric Oncology with Innovative ADC Modeling Merck leveraged ADC modeling and pediatric ADC dose optimization to enable FDA acceptance and advance…CertaraDecember 12, 2025
How to build standardized eCRFs across multiple EDC systems Blog How to build standardized eCRFs across multiple EDC systems Discover how to build standardized eCRFs across multiple EDC systems to improve data quality, accelerate…CertaraDecember 12, 2025
Certara Appoints Jon Resnick as Chief Executive Officer Press Release Certara Appoints Jon Resnick as Chief Executive Officer Resnick brings decades of leadership experience in health sciences, business operations, strategy, innovation and commercial…CertaraDecember 11, 2025
New Approach Methodologies: Redefining Animal Testing Alternatives PodcastPress Coverage New Approach Methodologies: Redefining Animal Testing Alternatives Explore how New Approach Methodologies (NAMs) and advanced in silico and in vitro tools are…CertaraDecember 10, 2025
Implementing AI in Medical Writing: Prepare Today for Tomorrow’s Efficiency [Japanese Webinar] Webinar Implementing AI in Medical Writing: Prepare Today for Tomorrow’s Efficiency [Japanese Webinar] CertaraDecember 10, 2025
7 key annotated CRF regulatory submission requirements you should know Blog 7 key annotated CRF regulatory submission requirements you should know Discover 7 key aCRF regulatory submission requirements for delivering high-quality annotated CRFs, including real-world examples…CertaraDecember 10, 2025
QSP Workshop 2026 in Japan & Korea – Mastering Scalable AI-enabled QSP modeling software, Certara IQ™ Live Events QSP Workshop 2026 in Japan & Korea – Mastering Scalable AI-enabled QSP modeling software, Certara IQ™ Japan: February 26, 2026 - 1:00 - 5:00 pm | Korea: Wednesday, March 4, 2026…CertaraDecember 9, 2025
On Virtual Twin® models in rare disease research, with Piet van der Graaf PodcastPress Coverage On Virtual Twin® models in rare disease research, with Piet van der Graaf Using Virtual Twin models in rare disease drug development can improve clinical trial design, regulatory…CertaraDecember 9, 2025
Virtual Triplets: The Next Step in Personalized and Ethical Drug Development Blog Virtual Triplets: The Next Step in Personalized and Ethical Drug Development Learn how virtual triplets, linking PBPK, QSP, and organ-on-a-chip technologies, are transforming model-informed drug development,…CertaraDecember 9, 2025